Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$479M |
| 2 |
Meta Platforms (Facebook)
META
|
+$465M |
| 3 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$445M |
| 4 |
Kenvue
KVUE
|
+$434M |
| 5 |
Micron Technology
MU
|
+$431M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$3.24B |
| 2 |
Apple
AAPL
|
+$1.9B |
| 3 |
Microsoft
MSFT
|
+$1.56B |
| 4 |
PepsiCo
PEP
|
+$1.34B |
| 5 |
JPMorgan Chase
JPM
|
+$1.34B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 43.54% |
| 2 | Technology | 19.7% |
| 3 | Financials | 7.47% |
| 4 | Consumer Discretionary | 6.7% |
| 5 | Communication Services | 6.02% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
4201
Hain Celestial
HAIN
$47.2M
| $221K | ﹤0.01% |
206,540
-1,666
| -0.8% | -$2.06K |
2013 Q2
50 quarters
|
|
4202
iShares ESG Aware MSCI EM ETF
ESGE
$7.01B
| $220K | ﹤0.01% |
+4,981
| New | +$220K |
2025 Q4
0 quarters
|
|
4203
OneWater Marine
ONEW
$164M
| $218K | ﹤0.01% |
20,192
-611
| -3% | -$8.15K |
2022 Q1
15 quarters
|
|
|
CBNA
4204
Chain Bridge Bancorp
CBNA
$310M
| $218K | ﹤0.01% |
6,303
+525
| +9% | +$17K |
2025 Q2
2 quarters
|
|
4205
Flexsteel Industries
FLXS
$363M
| $218K | ﹤0.01% |
5,527
+333
| +6% | +$13K |
2024 Q2
6 quarters
|
|
|
ANDG
4206
Andersen Group
ANDG
$1.06B
| $218K | ﹤0.01% |
+8,400
| New | +$211K |
2025 Q4
0 quarters
|
|
|
RMAX
4207
DELISTED
RE/MAX Holdings
RMAX
| $216K | ﹤0.01% |
28,503
+2,740
| +11% | +$22.2K |
2016 Q1
39 quarters
|
|
4208
Crexendo
CXDO
$197M
| $216K | ﹤0.01% |
33,426
+5,895
| +21% | +$38.6K |
2024 Q3
5 quarters
|
|
4209
Funko
FNKO
$328M
| $216K | ﹤0.01% |
63,555
+14,018
| +28% | +$44.1K |
2017 Q4
32 quarters
|
|
4210
Lightwave Logic
LWLG
$879M
| $216K | ﹤0.01% |
66,693
+66,679
| +476,279% | +$296K |
2022 Q2
14 quarters
|
|
4211
iShares iBonds Dec 2030 Term Corporate ETF
IBDV
$3.27B
| $216K | ﹤0.01% |
+9,789
| New | +$216K |
2025 Q4
0 quarters
|
|
4212
Biote Corp
BTMD
$33M
| $216K | ﹤0.01% |
82,942
+4,448
| +6% | +$12.2K |
2023 Q2
10 quarters
|
|
4213
Escalade
ESCA
$265M
| $215K | ﹤0.01% |
15,960
+1,711
| +12% | +$21.3K |
2023 Q2
10 quarters
|
|
4214
Treace Medical Concepts
TMCI
$286M
| $215K | ﹤0.01% |
87,664
+6,077
| +7% | +$26.4K |
2022 Q1
15 quarters
|
|
4215
Westwood Holdings Group
WHG
$187M
| $213K | ﹤0.01% |
12,396
+1,190
| +11% | +$20K |
2024 Q3
5 quarters
|
|
4216
Richardson Electronics
RELL
$282M
| $213K | ﹤0.01% |
19,606
-5,131
| -21% | -$54.7K |
2019 Q3
25 quarters
|
|
4217
Ocugen
OCGN
$346M
| $213K | ﹤0.01% |
+157,500
| New | +$224K |
2025 Q4
0 quarters
|
|
4218
Acme United Corp
ACU
$243M
| $213K | ﹤0.01% |
5,274
+575
| +12% | +$22.1K |
2024 Q3
5 quarters
|
|
4219
Motley Fool 100 Index ETF
TMFC
$2.12B
| $212K | ﹤0.01% |
2,960
-427
| -13% | -$30.5K |
2021 Q2
18 quarters
|
|
4220
Ero Copper
ERO
$3.95B
| $212K | ﹤0.01% |
7,508
+6,949
| +1,243% | +$162K |
2023 Q2
10 quarters
|
|
4221
FreightCar America
RAIL
$226M
| $212K | ﹤0.01% |
19,185
+16,192
| +541% | +$149K |
2025 Q3
1 quarter
|
|
|
KLC
4222
KinderCare Learning Companies
KLC
$220M
| $212K | ﹤0.01% |
49,087
+1,520
| +3% | +$7.66K |
2024 Q4
4 quarters
|
|
4223
PUT
Sable Offshore Corp
SOC
$673M
| $211K | ﹤0.01% |
23,400
-6,400
| -21% | -$60.4K |
2025 Q2
2 quarters
|
|
4224
iShares Gold Trust
IAU
$61.5B
| $211K | ﹤0.01% |
2,598
-19,120
| -88% | -$1.5M |
2022 Q1
15 quarters
|
|
4225
Adicet Bio
ACET
$60.8M
| $211K | ﹤0.01% |
25,000
+6,250
| +33% | +$69.1K |
2025 Q2
2 quarters
|
|
Similar funds
Barclays's Q4 2025 Portfolio in Review
As of Q4 2025, Barclays held 5,847 positions worth $417B, down 9.7% from $461B the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Barclays withdrew a net $23.5B in Q4 2025, closing 641 positions and reducing 1,714 holdings. Its most notable exit was Verona Pharma, an estimated $149M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 44% of assets, down from 44% a quarter earlier, followed by Technology and Financials.
Against the trend, Barclays opened a new position in The Magnum Ice Cream Company N.V. worth $156M.
- Barclays's largest Q4 2025 buy was The Magnum Ice Cream Company N.V.: 9,862,859 shares worth $156M.
- Barclays added most to Gilead Sciences in Q4 2025, an estimated $479M increase.
- Barclays's biggest Q4 2025 reduction was NVIDIA, cutting an estimated $3.24B.
- Barclays fully exited Verona Pharma in Q4 2025, selling an estimated $149M.
- Barclays's ten largest holdings make up 35% of its $417B portfolio in Q4 2025.
- Barclays opened 403 new positions and closed 641 in Q4 2025.
- Barclays's portfolio value fell 9.7% quarter-over-quarter to $417B.
Based on Barclays's 13F filing for Q4 2025, filed 13 Feb 2026.